WebNov 2, 2024 · SAN DIEGO, Nov. 02, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and … WebFind company research, competitor information, contact details & financial data for Maravai Life Sciences Holdings, LLC of San Diego, CA. Get the latest business insights from …
Shareholders in Maravai LifeSciences Holdings (NASDAQ:MRVI) …
WebApr 12, 2024 · MRVI stock opened at $13.71 on Wednesday. The company has a quick ratio of 7.31, a current ratio of 7.70 and a debt-to-equity ratio of 0.58. Maravai LifeSciences … WebMaravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. row of bathroom men
Maravai LifeSciences Reports Fourth Quarter and Full Year 2024 ...
WebNov 20, 2024 · (Reuters) - Shares of Maravai LifeSciences Holdings Inc MRVI.O, which provides a capping reagent to Pfizer and BioNTech for their COVID-19 vaccine, rose 18.3% in their market debut on Friday... WebGet the latest Maravai Lifesciences Holdings Inc (MRVI) real-time quote, historical performance, charts, and other financial information to help you make more informed … WebMar 23, 2024 · Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) shares, rose in value on Wednesday, 03/22/23, with the stock price down by -4.02% to the previous day’s close as strong demand from buyers drove the stock to $13.61. Actively observing the price movement in the last trading, the stock closed the ses st regis residences brickell